Release Date: 25/08/10 08:38 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 316.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%